Results 191 to 200 of about 5,359,290 (244)

Editorial: Molecular mechanisms in testicular germ cell tumors. [PDF]

Front Oncol
Lobo J, Acosta AM, Mego M.
europepmc   +1 more source

A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma. [PDF]

Cancer Cell Int
Krasic J, Soic D, Abramovic LS, Kolosnjaj I, Tomic M, Vrtaric A, Oguic SK, Gelo N, Bojanac AK, Jezek D, Mitrecic D, Ulamec M, Kulis T, Gornik O, Sincic N.   +14 more
europepmc   +1 more source

Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell Tumors. [PDF]

Urology
Baky FJ, Liso N, Williams B, Reuter VE, Tickoo SK, Feldman DR, Funt SA, Carver BS, Sheinfeld J, Matulewicz RS.   +9 more
europepmc   +1 more source

Non-Invasive miRNA Profiling for Differential Diagnosis and Prognostic Stratification of Testicular Germ Cell Tumors. [PDF]

Genes (Basel)
Vlachostergios PJ, Evmorfopoulos K, Zachos I, Dimitropoulos K, Thodou E, Samara M, Tzortzis V, Giakountis A.   +7 more
europepmc   +1 more source

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for. [PDF]

Front Genet
Parola S, Oing C, Rescigno P, Feliciano S, Carlino F, Pompella L, Marretta AL, De Santo I, Viggiani M, Muratore M, Facchini BA, Orefice J, Cioli E, Sparano F, Mallardo D, De Giorgi U, Palmieri G, Ascierto PA, Ottaviano M.   +18 more
europepmc   +1 more source

Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumors. [PDF]

Cancer Drug Resist
Kabelikova P, Ivovic D, Sumbalova Z, Karhanek M, Tatayova L, Skopkova M, Cagalinec M, Bruderova V, Roska J, Jurkovicova D.   +9 more
europepmc   +1 more source

MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge. [PDF]

Int J Mol Sci
Yodkhunnatham N, Pandit K, Puri D, Yuen KL, Bagrodia A.   +4 more
europepmc   +1 more source

An update on the genetic predisposition of testicular germ cell tumors. [PDF]

Transl Androl Urol
Islam R, Hansen A, Liesen A, Schorle H.
europepmc   +1 more source

Testicular germ cell tumors

, 1997
openaire   +1 more source

New Anti-Cancer Strategies in Testicular Germ Cell Tumors

Recent Patents on Anti-Cancer Drug Discovery, 2019
The most common solid malignancy of young men aged 20 to 34 years is testicular germ cell tumor. In addition, the incidence of these tumors has significantly increased throughout the last years.
Paolo Chieffi, Francesco Esposito, Marco De Martino   +2 more
exaly   +3 more sources